Welcome to our dedicated page for Nxu SEC filings (Ticker: NXU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nxu, Inc. (NXU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, registration statements, and listing‑related documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into how Nxu has described its business as a domestic technology company focused on energy storage and EV charging solutions, as well as key corporate events affecting shareholders.
Among the important documents for NXU is a Form 8‑K dated June 23, 2025, in which Nxu reports the termination of its previously announced merger agreement with Verde Bioresins, Inc. That filing explains the background of the proposed all‑stock merger, the conditions required for closing, and the company’s decision that it was no longer feasible to consummate the transaction. The same Form 8‑K also discusses Nasdaq listing compliance issues, the company’s 1‑for‑20 reverse stock split, and Nasdaq’s determination to delist Nxu’s securities from the Nasdaq Capital Market.
The June 23, 2025 Form 8‑K further discloses that Nxu’s Board of Directors determined it is in the best interests of the company and its stockholders for Nxu to pursue an orderly winding down and dissolution of the company, which may include seeking relief under bankruptcy laws, while noting that no assurance can be made regarding the company’s ability to conduct such a process. This filing is central for understanding Nxu’s stated plans for its corporate future.
Another key document is the Form 25 filed on August 7, 2025, by The Nasdaq Stock Market LLC. This notification of removal from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934 identifies Nxu, Inc. as the issuer and confirms the removal of its Class A common stock from listing and registration on Nasdaq. Together, these filings provide a regulatory record of Nxu’s delisting and its Board’s decision to pursue a wind‑down.
On Stock Titan, users can review Nxu’s SEC filings with AI‑powered summaries that highlight the main points of each document. This includes explanations of current reports on Form 8‑K, registration statements such as Form S‑4 related to the proposed merger, and listing documents like Form 25. The AI summaries are intended to make complex regulatory language more accessible, helping readers quickly understand topics such as merger terms, listing compliance, corporate governance changes, and the company’s stated plans for dissolution.
Nxu Inc. Schedule 13G/A shows that L1 Capital Global Opportunities Master Fund, Ltd. reports beneficial ownership of 286 shares of Class A common stock, representing 0.01% of the outstanding class. The filing clarifies these 286 shares are underlying warrants and refers to a prior Schedule 13G/A covering 1,500,000 shares purchased on December 27, 2024. The percent calculation uses 2,287,309 shares outstanding as of May 8, 2025, per the issuer's quarterly report. L1 Capital is organized in the Cayman Islands and lists David Feldman and Joel Arber as directors; David Feldman signed the amendment on behalf of the fund.
Nasdaq Stock Market LLC has filed a Form 25 to remove Nxu, Inc. (ticker NXU) Class A common stock from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. A Form 25 starts the delisting process; the security will generally be stricken from Nasdaq 10 days after filing and its registration terminated 90 days after, unless the SEC objects.
The filing states that Nasdaq "has complied with its rules" to strike the shares, indicating either an involuntary delisting (rule 12d2-2(b)) or issuer-initiated withdrawal (rule 12d2-2(c)); the document does not specify which box was checked. No financial data, earnings metrics or corporate statements are included. Once delisted, NXU will no longer be quoted on Nasdaq, likely moving to the OTC market, reducing liquidity, analyst coverage and index inclusion.
Nxu, Inc. (NASDAQ: NXU) filed an 8-K disclosing a series of adverse developments that collectively signal a likely cessation of operations.
Merger termination: On 23 Jun 2025 the company formally cancelled its October 2024 Agreement and Plan of Merger with privately held Verde Bioresins after concluding the required conditions—most notably shareholder approvals and Nasdaq listing acceptance—could not be met. The reverse split and other actions taken to facilitate the merger therefore lose relevance.
Nasdaq delisting: After back-to-back six-month grace periods and a 1-for-20 reverse split, Nxu still failed to meet the $1.00 bid requirement. Nasdaq’s Panel issued a delisting determination on 10 Jun 2025; the Board has elected not to seek further review. A Form 25-NSE is expected, leading to removal of the shares from listing and registration.
Orderly wind-down and potential bankruptcy: Facing loss of market access and strategic alternatives, the Board resolved on 23 Jun 2025 to pursue an orderly dissolution, which may include seeking bankruptcy protection. The filing cautions that no assurance can be given regarding timing or outcome.
Leadership departures: Effective 16 Jun 2025 President/Director Annie Pratt and CFO Sarah Wyant resigned, followed by Director Jessica Billingsley on 23 Jun 2025. The company states the departures are not due to disagreements.
Collectively, the 8-K reveals termination of the core growth transaction, imminent delisting, loss of key executives, and intent to liquidate—events that are profoundly negative for common shareholders.
FAQ
What is the current stock price of Nxu (NXU)?
What is the market cap of Nxu (NXU)?
